Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells.

Knödler A, Schmidt SM, Bringmann A, Weck MM, Brauer KM, Holderried TA, Heine AK, Grünebach F, Brossart P.

Leukemia. 2009 Mar;23(3):535-44. doi: 10.1038/leu.2008.301. Epub 2008 Nov 13.

PMID:
19005481
2.

hDectin-1 is involved in uptake and cross-presentation of cellular antigens.

Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Grünebach F, Brossart P.

Blood. 2008 Apr 15;111(8):4264-72. Epub 2007 Aug 13.

PMID:
17698636
3.

Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells.

Bringmann A, Schmidt SM, Weck MM, Brauer KM, von Schwarzenberg K, Werth D, Grünebach F, Brossart P.

Leukemia. 2007 Apr;21(4):732-8. Epub 2007 Feb 15.

PMID:
17301819
4.

TLR ligands differentially affect uptake and presentation of cellular antigens.

Weck MM, Grünebach F, Werth D, Sinzger C, Bringmann A, Brossart P.

Blood. 2007 May 1;109(9):3890-4. Epub 2007 Jan 11.

PMID:
17218388
5.

Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs.

Appel S, Bringmann A, Grünebach F, Weck MM, Bauer J, Brossart P.

Blood. 2006 Apr 15;107(8):3265-70. Epub 2005 Dec 27.

PMID:
16380452
6.

Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.

Heine A, Grünebach F, Holderried T, Appel S, Weck MM, Dörfel D, Sinzger C, Brossart P.

Mol Ther. 2006 Feb;13(2):280-8. Epub 2005 Oct 10.

7.

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways.

Appel S, Mirakaj V, Bringmann A, Weck MM, Grünebach F, Brossart P.

Blood. 2005 Dec 1;106(12):3888-94. Epub 2005 Aug 16.

PMID:
16105976
8.

Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.

Grünebach F, Kayser K, Weck MM, Müller MR, Appel S, Brossart P.

Cancer Gene Ther. 2005 Sep;12(9):749-56.

PMID:
15877082
9.

Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathways.

Appel S, Rupf A, Weck MM, Schoor O, Brümmendorf TH, Weinschenk T, Grünebach F, Brossart P.

Clin Cancer Res. 2005 Mar 1;11(5):1928-40.

10.

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

Dörfel D, Appel S, Grünebach F, Weck MM, Müller MR, Heine A, Brossart P.

Blood. 2005 Apr 15;105(8):3199-205. Epub 2004 Dec 23.

PMID:
15618468
12.

Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.

Schag K, Schmidt SM, Müller MR, Weinschenk T, Appel S, Weck MM, Grünebach F, Stevanovic S, Rammensee HG, Brossart P.

Clin Cancer Res. 2004 Jun 1;10(11):3658-66.

13.

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

Schmidt SM, Schag K, Müller MR, Weinschenk T, Appel S, Schoor O, Weck MM, Grünebach F, Kanz L, Stevanovic S, Rammensee HG, Brossart P.

Cancer Res. 2004 Feb 1;64(3):1164-70.

14.

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

Appel S, Boehmler AM, Grünebach F, Müller MR, Rupf A, Weck MM, Hartmann U, Reichardt VL, Kanz L, Brümmendorf TH, Brossart P.

Blood. 2004 Jan 15;103(2):538-44. Epub 2003 Sep 22.

PMID:
14504105
15.

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.

Schmidt SM, Schag K, Müller MR, Weck MM, Appel S, Kanz L, Grünebach F, Brossart P.

Blood. 2003 Jul 15;102(2):571-6. Epub 2003 Feb 6.

PMID:
12576330
16.

Molecular and functional characterization of human Dectin-1.

Grünebach F, Weck MM, Reichert J, Brossart P.

Exp Hematol. 2002 Nov;30(11):1309-15.

PMID:
12423684

Supplemental Content

Support Center